British tennis player Tara Moore has been provisionally suspended by the International Tennis Integrity Agency (ITIA) following a failed drugs test. The 29-year-old provided a sample which included substances on the World Anti-Doping Agency's (WADA) prohibited list. Samples taken were split and analysis of Sample A found traces of Nandrolone metabolites and Boldenone. Both are on WADA’s list of banned substances for 2022. “Ms Moore provided a sample whilst competing at a WTA tournament in Bogota, Colombia in April 2022. The sample was split into A and B samples and the subsequent analysis found that the A sample contained Nandrolone metabolites and Boldenone and its metabolite, which are prohibited substances listed in the 2022 World Anti-Doping Agency (WADA) Prohibited List. Adverse Analytic Findings for non-specified substances carry a mandatory provisional suspension. "I am investigating how the positive result could have occurred and look forward to proving that I am a clean athlete. I am deeply saddened by the provisional suspension and hope to be back on the court as soon as possible." Moore is ranked No.83 in the world for women’s doubles and participated in the French Open in May. She and partner American partner Emina Bektas reached the second round after beating Belinda Bencic and Anhelina Kalinina in their opening match. She has a singles ranking high of 145 and reached the second round at Wimbledon in 2016.